Absci (ABSI) closed at $12.10 on October 29, 2026, up 1.9% from the previous close, on volume of 3,999,110 shares (30-day average 4,224,979).
Data as of October 29, 2026.
29-Oct-2026
Absci to Participate in Upcoming Investor Conferences
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
Market Chameleon (Thu, 22-Oct 3:08 AM ET)
Absci’s AI Antibody Push Meets a New Bottleneck: Immune-Risk Screening Is Finally Scaling
Market Chameleon (Wed, 21-Oct 7:17 AM ET)
Globe Newswire (Wed, 21-Oct 10:00 AM ET)
Globe Newswire (Wed, 14-Oct 9:45 AM ET)
Market Chameleon (Tue, 13-Oct 5:32 AM ET)
Globe Newswire (Tue, 13-Oct 8:00 AM ET)
Globe Newswire (Thu, 24-Sep 8:00 AM ET)
Globe Newswire (Wed, 19-Aug 8:56 AM ET)
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
Globe Newswire (Tue, 11-Aug 4:05 PM ET)
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Absci trades on the NASDAQ stock market under the symbol ABSI.
As of October 29, 2026, ABSI stock price climbed to $12.10 with 3,999,110 million shares trading.
ABSI has a beta of 2.13, meaning it tends to be more sensitive to market movements. ABSI has a correlation of 0.08 to the broad based SPY ETF.
ABSI has a market cap of $2.08 billion. This is considered a Mid Cap stock.
Last quarter Absci reported $318,000 in Revenue and -$.21 earnings per share. This fell short of revenue expectation by $-949,336 and missed earnings estimates by -$.02.
In the last 3 years, ABSI traded as high as $12.54 and as low as $1.18.
The top ETF exchange traded funds that ABSI belongs to (by Net Assets): ARKG, XBI, VTI, IWM, VXF.
ABSI has outperformed the market in the last year with a price return of +176.9% while the SPY ETF gained +13.1%. ABSI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +75.4% and +36.3%, respectively, while the SPY returned +4.1% and 0.0%, respectively.
ABSI support price is $11.05 and resistance is $12.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABSI shares will trade within this expected range on the day.
